Wei Gao holds a Ph.D. in Cell Biology from Peking University and is a qualified patent attorney and legal professional. He has been recognized as a Gusu Outstanding Young IP Talent. Currently serving as Chief IP Officer (CIPO) of Beijing Hotgen Biotech , he has full responsibility for the patent portfolio strategy and protection of the company's R&D pipeline.
Earlier in his career, he worked as a patent examiner and part-time reexamination officer at the China National Intellectual Property Administration (CNIPA). He later joined a leading domestic patent service firm, where he practiced as a patent attorney, and subsequently held IP leadership roles at several well-known Chinese pharmaceutical companies. With extensive experience across pharmaceutical enterprises, IP firms, and the patent office, he possesses a deep understanding of the full lifecycle of intellectual property management. He has led the global patent strategy for multiple core drug pipelines, resolved patent disputes related to "drug-link" matters, and conducted BD/IP due diligence for major transactions, accumulating rich hands-on experience in the field.